LVAD (LEFT VENTRICULAR ASSIST DEVICE) THROMBOSIS

Clinical trials for LVAD (LEFT VENTRICULAR ASSIST DEVICE) THROMBOSIS explained in plain language.

Never miss a new study

Get alerted when new LVAD (LEFT VENTRICULAR ASSIST DEVICE) THROMBOSIS trials appear

Sign up with your email to follow new studies for LVAD (LEFT VENTRICULAR ASSIST DEVICE) THROMBOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could a new blood thinner prevent strokes and bleeding in heart pump patients?

Disease control Not yet recruiting

This study compares two blood thinners—apixaban and warfarin—in people with advanced heart failure who have a HeartMate 3 heart pump. The goal is to see which drug better prevents serious problems like stroke, blood clots, and major bleeding. About 460 adults who have had the pum…

Matched conditions: LVAD (LEFT VENTRICULAR ASSIST DEVICE) THROMBOSIS

Phase: PHASE3 • Sponsor: Columbia University • Aim: Disease control

Last updated May 17, 2026 03:56 UTC

LVAD (LEFT VENTRICULAR ASSIST DEVICE) THROMBOSIS

Get alerted when new LVAD (LEFT VENTRICULAR ASSIST DEVICE) THROMBOSIS trials appear

Could a new blood thinner prevent strokes and bleeding in heart pump patients?